1 / 22

ACNE

ACNE. Dr. Sandeep Rondla South Birmingham VTS. Introduction. Acne is a disease of pilosebaceous follicles present on the face and the upper trunk and are under androgenic control. Affects most of the adolescent population, in 20% of these it is clinically significant

jadyn
Download Presentation

ACNE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ACNE • Dr. Sandeep Rondla • South Birmingham VTS

  2. Introduction • Acne is a disease of pilosebaceous follicles present on the face and the upper trunk and are under androgenic control. • Affects most of the adolescent population, in 20% of these it is clinically significant • Both sexes involved, peak at 16 - 20 years • In chronic disease, it persists till the mid 20s, in 7% until 40-50 yrs. • Rare in infancy

  3. Aetiology • 3 types of follicles in the skin : hair (beard), vellus and sebaceous • Acne involves sebaceous follicles - seen on face, back and chest. • Factors in acne formation • increased sebum production • ductal hyperprolifertaion (comedone formation) • colonisation of the duct with Propionibacterium acnes • inflammation • inflamation

  4. Increased sebum production • Patients with acne produce more sebum than controls • No evidence of significant hormonal abnormalities, hence do not need investigation • Evidence suggests that acne is an end-organ hyper-response of sebaceous glands to circulating hormones • Androgens of adrenal and gonadal origin stimulate sebum production

  5. comedone formation whitehead Vs blackhead • Comedone formation is the result of ductal corneocytes accumulating in the ductal lumen. • Comedone present clinically as blackheads and whiteheads • A whitehead is referred as a closed comedone as it very small orifice with many proinflammatory substances in the duct contents. • A black head is referred to as a open comedone with large orifice. • Whiteheads are more prone to develop into inflammatory lesions than blackheads. • Treatment should be aimed at reducing microcomedones which usually precede these lesions.Topical retinoids are the treatment of choice.

  6. comedone formation

  7. P.acnes • Normal commensal of the skin, esp in sebum rich areas • Infection occurs when there is colonisation of the pilosebaceous duct with p. acne, usually early after comedone formation • Exact mechanism of colonisation is not known • Evidence suggests : role of micro-environment in acne prone glands

  8. inflammation • Inflammation is type IV cell mediated immune reaction • Specific antigen not identified • In pustule stage : polymorphonuclear leucocytes • In intense papular stage : giant cell response with associated duct rupture • Inflammation leads to scarring due to loss of or increase collagen

  9. clinical features • Seborrhoea - greasiness • Comedones • Superficial inflamed lesions - papules, pustules, macules • Deep inflamed lesions - nodules and deep pustules • Scars • Post inflammatory pigmentation

  10. acne grading • MILD - Predominantly consists of non-inflammatory comedones • MODERATE - Mixture of non-inflammatory comedones and inflammatory papules and pustules • SEVERE - Presence of nodules and cysts along with preponderance of inflammatory papules and pustules

  11. differential diagnosis • Perioral dermatitis • Seborrhoeic eczema • Rosacea • Pomade acne • Steroid induced acne Pomade acne

  12. investigations • Rarely needed • Hormonal investigations to be done if hirsuitism or very irregular menses (PCOD) • Erythromycin resistant P. acne seen in 65% and tetracycline resistance seen in 20% - culture might be useful • Patients on minocycline should have blood tests 6 monthly to check LFTs, ANF and pANCA • If starting on oral isoretinoin - liver enzymes and lipids at baseline / 1 month after starting treatment and every 3 months there after • Pregnancy test - pre therapy and 5 weeks post therapy. Monthly pregnancy test recommended.

  13. treatment principles • Discussion with patient • Choice of Topical therapy • Choice of Oral therapy • Choice of Physical therapy • Combined therapy

  14. discussion with the patient • Time spent by the general practioner in discussing acne with the patient should emphasise the following : • Acne is a chronic disease. • A treatment strategy is needed and it is likely that long therapy will be required. • Acne is a slow responding disorder with little improvement in the first 3-5 weeks. • There is a need for continued compliance • There is no evidence that fatty foods or chocolate adversely affect acne. • Certain physiological events may influence acne,for example :stress may make acne worse • Premenstrual flare is common in 70% of females. Sunshine often helps acne but often temporarily.

  15. topical therapy • Mild disease • Combination with oral antibiotics in moderate disease • Combination with hormonal therapy in females • Maintenance therapy after oral therapy has been discontinued

  16. topical therapy

  17. oral therapy

  18. DIANETTE • Dianette has a product license for severe acne but is not licensed as an oral contraceptive in the UK. • It achieves improvement in 75 - 90 % of female patients. • Relative risk of VTE is slightly higher compared to other COC pills • Should be withdrawn 3 to 4 cycles after the acne is clear • Once Acne is clear - low androgenic effect pill like Marvelon , Cilest or Yasmin prescribed for contraception rrequired

  19. treatment failure • Wrong Diagnosis • Compliance Problems - common problem. Must be stressed to patient • P.acnes Resistance - increasing problem. Commonly seen with Erythromycin & Clindamycin

  20. referral guidelines to secondary care - NICE • Patients who have severe physical disease. • Patients who have moderate disease but have failed to respond to 6 months of adequate oral and topical therapy. • Patients in whom there are significant psycho-social problems from acne. • Patients with significant problems with scarring / who may be at risk of scarring. • Patients suspected of significant hormonal disease.

  21. treatment algorithm Acne grade Choice of treatment Maintenance therapy Mild acne (Comedones +/- inflammatory lesions Topical retinoids +/- Benzoyl peroxide / Topical antibiotics Success Failure Combination therapy Oral Antibiotic + Topical retinoid +/- Benzoyl peroxide Success Moderate acne (mild to moderate papular / pustular) Topical retinoids +/- Benzoyl peroxide Failure Systemic isoretinoin +/- Hormonal therapy (females) Success Severe acne (severe nodulocystic)

  22. Thank You • Questions

More Related